Novo's Wegovy pill to test demand from consumers with cash
LONDON, Dec 23 (Reuters) - Novo Nordisk's newly approved weight-loss pill version of Wegovy will be a test case for the fast-growing cash-paying consumer market, with plans for the first highly effective oral treatment to go straight to U.S. self-pay...
Reuters